Can antiplatelet therapy after drug eluting stent become a problem?
Many clinical trials demonstrate that demonstrate drug-eluting stents (DES) can improve procedural success in patients with acute coronary syndromes, with a remarkable reduction in the rate of restenosis. On the other hand, it has been shown that stenting can also increase the rate of thrombotic com...
Furkejuvvon:
| Váldodahkki: | |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
SEEd
2009-03-01
|
| Ráidu: | Clinical Management Issues |
| Fáttát: | |
| Liŋkkat: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/556 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|